Health
Behind R.F.K. Jr.’s Vow to ‘Follow the Science’ on Vaccines
Robert F. Kennedy Jr. spent the first day of his back-to-back confirmation hearings deftly avoiding questions about his views on vaccines. On the second day, when a prominent Republican senator insisted there was no link between vaccines and autism, Mr. Kennedy shot back that a new study “showed the opposite.”
“I just want to follow the science,” Mr. Kennedy declared.
Following the science has been a familiar refrain for Mr. Kennedy, whose confirmation as health secretary appears all but assured in a vote expected Thursday. But the exchange in the Senate raises questions about just what type of science Mr. Kennedy is consulting. It foreshadows how, if confirmed, Mr. Kennedy could continue to sow doubts about vaccines.
Academics have pounced on the study that Mr. Kennedy cited during the hearing, shredding it as methodologically faulty and biased. The study emanated from a network of vaccine skeptics who share some of Mr. Kennedy’s views — an ecosystem that includes the author of the study, the editor of the journal that published it and the advocacy group that financed it.
“We authors were delighted and honored that R.F.K. Jr. referred to our work in his confirmation hearing,” the study’s lead author, Anthony Mawson, said in an email. A spokeswoman for Mr. Kennedy did not respond to a request for comment.
Dr. Mawson, an epidemiologist, said he first met Mr. Kennedy at an autism conference in 2017. Mr. Kennedy cites Dr. Mawson’s research 33 times in his 2023 book, “Vax-Unvax: Let the Science Speak.”
His study was rejected “without explanation” by several mainstream medical journals, Dr. Mawson said. So he turned for advice to Andrew Wakefield, the author of the 1998 study, now retracted, that sparked the initial furor over vaccines and autism. Mr. Wakefield encouraged him to submit the study to a new journal called Science, Public Health Policy and the Law.
That publication is led by some notable vaccine critics, including three who headlined a Washington rally in 2022 with Mr. Kennedy to protest Covid vaccine mandates.
As the nation’s health secretary, Mr. Kennedy “would have wide powers to advance his favored research studies, publications, or scientific data,” according to Lawrence O. Gostin, a public health law expert at Georgetown University. Mr. Kennedy’s critics fear that the public will have neither the time nor the training to sort through a war that seems to pit one study against another, and that the result will be a rapid decline in confidence in vaccines.
“The Mawson paper epitomizes Kennedy’s consistent inability to distinguish junk science from reliable information,” said Dr. John P. Moore, professor of microbiology and immunology at Weill Cornell Medical College, who said that study and some of the others Mr. Kennedy has cited in the past are published by “fringe journals.”
Mr. Kennedy has said that he is not anti-vaccine, but rather in favor of vaccine safety.
“I support the measles vaccine. I support the polio vaccine,” Mr. Kennedy said on the first day of his confirmation hearings. “I will do nothing as H.H.S. secretary that makes it difficult or discourages people from taking it.”
Mr. Kennedy’s insistence that more research is necessary when it comes to vaccine safety has drawn support from some Republicans, who say they welcome his skepticism.
“I don’t understand why my colleagues all of sudden say we can’t question science,” Senator Markwayne Mullin, Republican of Oklahoma, said during one of Mr. Kennedy’s hearings. He added, “When you start looking at the rise of autism, why wouldn’t we be looking at everything?”
But Michael T. Osterholm, an epidemiologist at the University of Minnesota who has advised administrations of both parties, said Mr. Kennedy’s demands for additional data go too far when they concern vaccines and autism. Mainstream scientists say the issue is settled.
“That’s the equivalent of me saying until Newton comes back and shows me that apple falling from the tree, I do not believe gravity exists,” Dr. Osterholm said.
Doctors who have examined the way Mr. Kennedy uses scientific research say he also has a tendency to cherry-pick particular findings from prominent researchers, as he did during a podcast in 2022.
During that appearance, he cited a study published in the journal Pediatrics in 2000 to suggest that improvements in sanitation and hygiene — and not vaccines — fueled a drop in deaths from infectious diseases during the first half of the 20th century. That is true. But Mr. Kennedy failed to note that the study also reported that vaccines introduced in the second half of the 20th century had “virtually eliminated” deaths from diseases including polio and measles.
During one of his confirmation hearings, Mr. Kennedy cited work by a well-known vaccine scientist, Dr. Gregory Poland, to suggest Black people should follow a different vaccine schedule because they needed fewer antigens, the vaccine components that provoke an immune response.
Dr. Poland did not respond to requests for comment. But he told National Public Radio that his work did not support Mr. Kennedy’s assertion.
Mr. Kennedy and Dr. Mawson have long aired similar concerns about vaccines.
In an appearance before the Mississippi legislature in 2009, Dr. Mawson called for more vaccine safety research and “a more flexible approach to vaccination requirements for school attendance.” In a 2011 lawsuit, Dr. Mawson said the testimony had cost him his job as an epidemiologist at the University of Mississippi Medical Center.
In 2017, Dr. Mawson published a pilot study comparing vaccinated to unvaccinated children.
The study relied on a survey of parents who home-schooled their children and found higher rates of autism among vaccinated children, compared with those who had not been vaccinated. The study was funded in part by Generation Rescue, a nonprofit associated with Jenny McCarthy, a television personality who has promoted claims of a link between vaccines and autism.
Dr. Mawson by that time had established the Chalfont Research Institute, a charity that operates out of his home in Jackson, Miss. The institute reported revenue of just $57 in 2021, the most recent figures available.
In 2019, it received charitable contributions of $160,000, tax records show. The bulk of that money, $150,000, came from the National Vaccine Information Center, a group whose mission includes supporting research on “vaccine-associated deaths, injuries and chronic illness.”
Like Mr. Kennedy, the group’s president and co-founder, Barbara Loe Fisher, has long called for research comparing “total health outcomes” including the risk of autism, in vaccinated and unvaccinated children. When Dr. Mawson approached her group with a proposal, she said, the center reviewed his pilot study of 2017, approved his plan and provided $150,000 in funding.
That money paid for the paper Mr. Kennedy cited at the hearing, during an exchange with Senator Bill Cassidy, Republican of Louisiana and a doctor.
The journal that published the study, Science, Public Health Policy and the Law, advertises itself as peer-reviewed, meaning its research is evaluated by anonymous independent experts before publication. Dr. Mawson said his paper had undergone review by two such experts.
Some people associated with the journal are also associated with Mr. Kennedy.
James Lyons-Weiler, the journal’s editor in chief, described himself as a longtime ally of Mr. Kennedy’s in a yearslong “fight across 20 states” for vaccine exemptions.
“Honored to call him my friend,” he wrote on social media last year.
The journal’s editorial board includes the chief executive and the chief scientific officer of Children’s Health Defense, the nonprofit that Mr. Kennedy led until he began his presidential campaign in 2023.
The board also includes members who sell products or services for people who are concerned about vaccines. One of its editorial board members offers $2,350 telehealth appointments for “post-vaccine syndrome.” Another sells $90 “spike detox” supplements marketed for “vaccine injury syndrome” that is meant to get “you back to that pre-Covid feeling.”
The study by Dr. Mawson that Mr. Kennedy cited at the hearing focused on about 47,000 children enrolled in Florida Medicaid from 1999 to 2011 and looked at billing data to determine their vaccination status.
The study found very few billing records for unvaccinated children with autism — eight who were born prematurely and 54 overall. It concluded that vaccination was significantly associated with higher rates of neurodevelopmental disorders, including autism, particularly in infants who were born prematurely.
By contrast, large-scale studies in respected medical journals, including an analysis of five studies involving more than 1.2 million children, have found no association between vaccines and autism.
But even as Dr. Mawson’s research took shape, problems emerged. The paper notes that researchers lost access to the database they used to perform the study. Dr. Alex Morozov, an expert on clinical trial design who met with Dr. Mawson to discuss the study, said he viewed that as a red flag.
Dr. Morozov also said the study had a “fundamental flaw”: It failed to account for the possibility that vaccinated children might have more encounters with the medical system than unvaccinated children, whose illnesses would not be captured by billing data.
The study also failed to account for factors like family history of autism, the child’s gender (boys are diagnosed with higher rates of autism than girls) or the possibility that children might have been vaccinated outside the Florida Medicaid system, said Bertha Hidalgo, an associate professor of epidemiology at the University of Alabama at Birmingham.
Dr. Mawson strongly defended the work, noting that the study “carefully documents both its strengths and limitations,” but contending that critics focused only on the limitations. “Nevertheless,” he said, “further research is needed to replicate the findings and to unravel the mechanisms involved.”
At the Senate hearing, Mr. Cassidy pressed Mr. Kennedy to accept that the vaccines and autism debate was settled. He reminded Mr. Kennedy that he had been shown the study of 1.2 million children that found no link between the two.
“I’m a doc, trying to understand,” Mr. Cassidy said, adding, “Convince me that you will become the public health advocate, but not just churn old information so that there’s never a conclusion.”
To that, Mr. Kennedy replied, “I’m going to be an advocate for strong science. You show me those scientific studies, and you and I can meet about it. And there are other studies as well. I’d love to show those to you.”
Health
Giant golden spiders could spread this summer; experts downplay health risk
NEWYou can now listen to Fox News articles!
Large, palm-sized spiders are spinning massive golden webs across porches and power lines, and, according to experts, they’re here to stay.
The Joro spider, which has a leg span up to 4 inches and markings of neon yellow, blue-black and red, was first recorded in Georgia in 2013.
Since its arrival — likely as a hitchhiker on a shipping container or an airplane from Asia, experts say — the arachnid has been steadily marching north.
DOZENS SICKENED AS POTENTIALLY DEADLY FUNGUS SPREADS IN SOUTHERN STATE
The spiders have so far been spotted in Georgia, North Carolina, South Carolina and Tennessee.
They are expected to spread throughout eastern North America, at least as far north as Pennsylvania and possibly further in warmer, coastal areas, according to Penn State.
Joro spiders can “fly” by shooting out silk parachutes that carry them on the wind. (Stuart Cahill/Boston Herald)
To travel, the spider uses a technique called “ballooning,” in which hatchlings release fine silk threads that catch air currents and carry them over long distances.
Ian Williams, an entomologist with Orkin, said he counted 200 adult spiders by September of last year on his one-acre property near Atlanta.
POPULAR HONEYMOON DESTINATION FACES AVIAN MALARIA THREAT, SPREAD BY MOSQUITOES
“They’re quite intimidating looking spiders, and they make very large webs,” he told Fox News Digital. “The webbing itself, if it catches the sunlight, has a golden hue to it. And it’s very strong.”
CLICK HERE FOR MORE HEALTH STORIES
Despite the arachnid’s striking appearance, experts agree that people shouldn’t panic. Research shows the Joro is among the “shyest” spiders ever documented. When disturbed, they often sits motionless for over an hour rather than attacking.
Joro spiders like to spin their webs up high near houses, trees and even power lines, an expert said. (Stuart Cahill/Boston Herald)
“While they’re large spiders, they don’t have large fangs. And, so, it’s difficult for them to bite humans,” Williams noted.
Even in the rare event of a nip, the expert said the venom is weak, comparable to a localized bee sting, and carries “no medical importance.”
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
As an invasive species, the Joro’s impact is still being weighed by scientists.
“One of the big concerns is that they potentially out-compete native species of spiders,” Williams said.
Physical removal is more efficient than pesticides, according to an expert. (iStock)
A prolific hunter, the Joro spider catches everything from mosquitoes to large, meaty insects like cicadas. It is unclear whether it steals food from native garden spiders.
To prevent Joro spiders from nesting on your porch or property, experts recommend using a broom or long pole to knock the web down.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
“Spiders may get the message, ‘Hey, I’m not going to keep remaking my same web in the same area,’” Williams said.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
Physical removal is more effective than pesticides, which often miss the spiders in their high, open-air webs.
For those who spot a Joro spider in a new area, experts suggest logging the sighting on apps like iNaturalist to help researchers track their northern migration.
Health
Another state bans ‘gas station heroin’ as officials warn of deadly risks
NEWYou can now listen to Fox News articles!
Top stories
→ ‘Gas station heroin’ banned in another state amid nationwide crackdowns
→ New COVID variant spreads across US as CDC raises concerns
→ The real reasons you’re still exhausted after 8 hours of sleep
FDA Commissioner Martin Makary says tianeptine poses a “dangerous and growing health trend.” (Markus Scholz/picture alliance via Getty Images)
Conversation-starters
→ March Madness sparks surprising surge in men’s sexual procedure
→ Cannabis benefits called into question in major study
→ ‘Call a Boomer’ payphones help cure loneliness across generations
Along a bustling sidewalk in Boston, a bright yellow payphone invites folks to “Call a Boomer.” (Matter Neuroscience)
Food for thought
→ Eating meat tied to lower dementia risk, study suggests
→ Stomach issues might have nothing to do with eating habits
→ Why your sugar cravings won’t go away, even after cutting sweets
CLICK HERE FOR MORE HEALTH STORIES
Health
Dementia risk signals could lie in simple blood pressure readings, researchers say
NEWYou can now listen to Fox News articles!
Simple measurements taken during routine blood pressure checks could predict dementia risk years before symptoms appear.
That’s according to new research presented this week at the American College of Cardiology’s Annual Scientific Session in Louisiana.
The findings draw on two studies led by researchers at Georgetown University, which suggest that monitoring how blood vessels age and stiffen over time can provide a window into future cognitive health.
LURKING DEMENTIA RISK EXPOSED BY BREAKTHROUGH TEST 25 YEARS BEFORE SYMPTOMS
Data shows rates of dementia and aging-related cognitive decline are expected to increase as populations age, and half of U.S. adults have high blood pressure (hypertension).
Scientists believe that efforts to better address hypertension, a key contributor to heart disease and a risk factor for dementia, could affect both cardiac and brain health.
Data shows rates of dementia and aging-related cognitive decline are expected to increase as populations age. Meanwhile, half of U.S. adults have high blood pressure. (iStock)
“Blood pressure management isn’t just about preventing heart attacks and strokes; it may also be one of the most actionable strategies for preserving cognitive health,” Dr. Newton Nyirenda, the study’s lead author and an epidemiologist at Georgetown University in Washington, said in a press release.
The research focused on two metrics, the pulse pressure-heart rate index and estimated pulse wave velocity. Both were calculated using data collected during standard doctor visits, such as heart rate, age and blood pressure.
“Blood pressure management isn’t just about preventing heart attacks and strokes; it may also be one of the most actionable strategies for preserving cognitive health.”
Researchers examined five years of data patterns for more than 8,500 people in the SPRINT trial, a large study of adults 50 years and older with hypertension. In the follow-up, 323 of the participants developed probable dementia.
HIDDEN BRAIN CONDITION MAY QUADRUPLE DEMENTIA RISK IN OLDER ADULTS, STUDY SUGGESTS
In one study, the team found the pulse pressure-heart rate index was a strong independent predictor of dementia risk in adults over 50. For participants under 65, every one-unit increase was associated with a 76% higher risk of developing dementia.
For participants under 65, an increase in the pulse pressure-heart rate index was associated with a 76% higher risk of developing dementia. (iStock)
The second study found that adults with consistently elevated or rapidly increasing pulse wave velocity were more likely to develop dementia than those with stable velocity, even after accounting for factors like smoking, gender and cardiovascular history.
CLICK HERE FOR MORE HEALTH STORIES
“Our findings suggest that vascular aging patterns may provide meaningful insight into future dementia risk,” said Nyirenda. “This reinforces the idea that managing vascular health earlier in life may influence long-term brain health.”
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
The team emphasized that clinicians should tailor risk assessments and treatment strategies to the individual.
Further studies are needed to confirm these parameters and determine whether changing vascular aging trajectories reduces dementia risk. (iStock)
“You don’t want to wait until a patient starts manifesting cognitive decline before you act,” said senior study author Sula Mazimba, an associate professor at the University of Virginia.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
Researchers noted the study could not establish causation. Other limitations included the fact that participants already had hypertension and elevated cardiovascular risk, meaning the findings may not apply to people without those conditions.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
Further studies are needed to confirm these findings and to determine whether improving blood vessel health over time could reduce dementia risk.
-
Detroit, MI1 week agoDrummer Brian Pastoria, longtime Detroit music advocate, dies at 68
-
Movie Reviews1 week ago‘Youth’ Twitter review: Ken Karunaas impresses audiences; Suraj Venjaramoodu adds charm; music wins praise | – The Times of India
-
Sports7 days agoIOC addresses execution of 19-year-old Iranian wrestler Saleh Mohammadi
-
New Mexico5 days agoClovis shooting leaves one dead, four injured
-
Business1 week agoDisney’s new CEO says his focus is on storytelling and creativity
-
Technology6 days agoYouTube job scam text: How to spot it fast
-
Tennessee4 days agoTennessee Police Investigating Alleged Assault Involving ‘Reacher’ Star Alan Ritchson
-
Texas1 week agoHow to buy Houston vs. Texas A&M 2026 March Madness tickets